Xeris Pharmaceuticals
XERS
10.11
+0.04
+0.40%
Xeris Pharmaceuticals
US · XERS
#2862 by market cap
Listed 2018
10.11
+0.04
+0.40%
Live - 5344 symbols - heartbeat 330s ago
· 2026-10-08 07:22
Pre-market
10.04
-0.69%
After-hours
10.00
-1.09%
- Market cap
- 1.84B
- P/E (TTM)i
- -104.23
- P/Bi
- -190.75
- EPSi
- 0.00
- Div yieldi
- 0.00%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on XERS?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 5 analysts
Buy
Avg price target
12.00 +18.7%
Price target rangecurrent 10.11
Low8.00
Avg12.00
High16.00
Buy 80%
Hold 20%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-06 | Barclays | -- | BUY | 14.00 |
| 2026-09-29 | Craig-Hallum | -- | BUY | 12.00 |
| 2026-09-21 | H.C. Wainwright | -- | BUY | 10.00 |
| 2026-09-10 | Craig-Hallum | -- | BUY | 12.00 |
| 2026-09-10 | Piper Sandler | -- | HOLD | 8.00 |
| 2026-09-10 | Leerink Partners | -- | BUY | 16.00 |
| 2026-09-10 | H.C. Wainwright | -- | BUY | 10.00 |
| 2026-08-20 | Barclays | -- | BUY | 12.00 |
| 2026-08-07 | Piper Sandler | -- | HOLD | 8.00 |
| 2026-08-07 | H.C. Wainwright | -- | BUY | 10.00 |
| 2026-07-08 | Craig-Hallum | -- | BUY | 12.00 |
| 2026-06-30 | Craig-Hallum | -- | BUY | -- |
| 2026-06-11 | Craig-Hallum | -- | BUY | -- |
| 2026-05-13 | Barclays | -- | BUY | 9.00 |
| 2026-05-08 | Craig-Hallum | -- | BUY | 12.00 |
| 2026-05-08 | H.C. Wainwright | -- | BUY | 10.00 |
| 2026-05-06 | Craig-Hallum | -- | BUY | -- |
| 2026-04-28 | Craig-Hallum | -- | BUY | 12.00 |
| 2026-03-19 | Barclays | -- | BUY | 9.00 |
| 2026-03-03 | Craig-Hallum | -- | BUY | -- |
| 2026-03-02 | H.C. Wainwright | -- | BUY | 10.00 |
| 2026-02-27 | Craig-Hallum | -- | BUY | -- |
| 2026-01-30 | Craig-Hallum | -- | BUY | -- |
| 2026-01-09 | H.C. Wainwright | -- | BUY | 10.00 |
| 2026-01-08 | Craig-Hallum | -- | BUY | -- |
Quant vs Street three independent views, side by side
StockVane factor grade
D
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±17.02% | -9.25% (in line) |
| 2026/Q1 | 2026-05-07 | -- | ±15.70% | +4.08% (in line) |
| 2025/Q4 | 2026-03-02 | -- | ±23.00% | -1.63% (in line) |
| 2025/Q3 | 2025-11-06 | -- | ±14.65% | -21.88% (beat) |
| 2025/Q2 | 2025-08-07 | -- | ±14.75% | +20.22% (beat) |
| 2025/Q1 | 2025-05-08 | -- | ±17.63% | +15.18% (in line) |
| 2024/Q4 | 2025-03-06 | -- | ±40.00% | +9.55% (in line) |
| 2024/Q3 | 2024-11-08 | -- | ±32.44% | +3.27% (in line) |
| 2024/Q2 | 2024-08-08 | -- | ±26.76% | +4.69% (in line) |
| 2024/Q1 | 2024-05-09 | -- | ±30.27% | +1.62% (in line) |
| 2023/Q4 | 2024-03-06 | -- | ±27.60% | -19.48% (in line) |
| 2023/Q3 | 2023-11-09 | -- | ±37.88% | -8.84% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:22:20 · For reference only, not investment advice and not tailored to your situation.